CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 365 enrolled
Drug / intervention
Masimo INVSENSOR00057device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06071754
NCT06071754N/ACompleted
CompareCT.gov

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

Masimo Corporation·interventional·Posted Oct 6, 2023·Updated Oct 31, 2025

In Brief

A clinical study evaluating Masimo INVSENSOR00057 for Healthy and Atrial Fibrillation. Completed, enrolled 365 participants across 4 sites.

Detailed Summary

The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Atrial Fibrillation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 6, 2023
Enrollment StartSep 1, 2023
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.7 years ago

Interventions

Masimo INVSENSOR00057device

Masimo INVSENSOR00057 will be used to collect electrocardiogram measurements.